MAPT and Alzheimer disease: The remarkable specificity exhibited by PAapt AuNPs in their ability to selectively identify tau proteins and amyloid‐beta (1‐42) oligomers, while remaining unaffected by the presence of non‐target proteins, renders them highly promising candidates for the development of efficient clinical diagnostic tools aimed at detecting multiple protein biomarkers associated with AD.